Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets.

Abstract 1,25-dihydroxycholecalciferol, the active form of vitamin D, was administered orally in doses of 1.3 to 2.7 μg per day to four patients with hypophosphatemic, vitamin-D-resistant rickets t...

[1]  S. Massry,et al.  Study of intestinal absorption of calcium in patients with renal failure. , 1973, Kidney international.

[2]  J. Bilezikian,et al.  Familial Hyperparathyroidism: Mild Hypercalcemia in at Least Nine Members of a Kindred , 1973 .

[3]  L. Rosenberg,et al.  Familial Hypophosphatemic Rickets: Defective Transport of Inorganic Phosphate by Intestinal Mucosa , 1973, Science.

[4]  J. Haddad,et al.  Serum concentrations of 25-hydroxyvitamin D in sex-linked hypophosphatemic vitamin D-resistant rickets. , 1973, The Journal of laboratory and clinical medicine.

[5]  R. G. Wong,et al.  Biological activity of the vitamin D metabolite 1,25-dihydroxycholecalciferol in chickens and rats. , 1972, The Journal of nutrition.

[6]  A. Norman,et al.  Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. , 1972, The New England journal of medicine.

[7]  H. DeLuca,et al.  The Acute Renal Tubular Effects of 1,25-Dihydroxycholecalciferol , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[8]  F. Glorieux,et al.  Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. , 1972, The New England journal of medicine.

[9]  J. Lewy,et al.  Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets. , 1972, The Journal of pediatrics.

[10]  M. Garabédian,et al.  25-Hydroxycholecalciferol. A comparative study in deficiency rickets and different types of resistant rickets. , 1972, The Journal of clinical investigation.

[11]  J. Puschett,et al.  Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium, and calcium. , 1972, The Journal of clinical investigation.

[12]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[13]  J. Smith,et al.  The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. , 1971, The Journal of clinical investigation.

[14]  H. DeLuca,et al.  Competitive binding assay for vitamin D and 25-OH vitamin D. , 1971, The Journal of clinical endocrinology and metabolism.

[15]  F. Glorieux,et al.  Serum Parathyroid Hormone in X-Linked Hypophosphatemia , 1971, Science.

[16]  Harrison He,et al.  Familial hypophosphatemic rickets showing autosomal dominant inheritance. , 1971 .

[17]  A. Norman,et al.  Vitamin D: A Cholecalciferol Metabolite Highly Active in Promoting Intestinal Calcium Transport , 1971, Science.

[18]  D. Fraser,et al.  Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite , 1970, Nature.

[19]  H. DeLuca,et al.  Effects of 25-hydroxycholecalciferol in patients with familial hypophosphatemia and vitamin-D-resistant rickets. , 1970, The New England journal of medicine.

[20]  A. Gilman.  A protein binding assay for adenosine 3':5'-cyclic monophosphate. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[21]  E. Schoen,et al.  Severe familial hypophosphatemic rickets. Normal growth following early treatment. , 1970, American journal of diseases of children.

[22]  H. DeLuca,et al.  "Activation" of vitamin D by the liver. , 1969, The Journal of clinical investigation.

[23]  J. Phang,et al.  EFFECT OF DIVIDED CALCIUM INTAKE ON URINARY CALCIUM EXCRETION , 1968 .

[24]  J. Canterbury,et al.  A Radioimmunoassay for Parathyroid Hormone in Man∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25]  F. Rector,et al.  Familial vitamin D-resistant rickets. Study of six cases with evaluation of the pathogenetic role of secondary hyperparathyroidism. , 1968 .

[26]  G. Aurbach,et al.  Parathyroid function and the renal excretion of 3'5'-adenylic acid. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Barbour,et al.  Studies on the mechanism of phosphorus excretion in vitamin D resistant rickets. , 1966, Nephron.

[28]  C. Dent,et al.  Hypophosphataemic Osteomalacia with Complete Recovery , 1964, British medical journal.

[29]  E. Reiss,et al.  Vitamin-D-resistant rickets: the effect of calcium infusion on phosphate reabsorption. , 1960, The Journal of clinical investigation.

[30]  Richmond W. Smith,et al.  Phosphate diabetes. A case study of osteomalacia. , 1958 .

[31]  G. Fanconi,et al.  Tubular Insufficiency and Renal Dwarfism* , 1954, Archives of disease in childhood.

[32]  F. Albright,et al.  The accumulation, interpretation, and presentation of data pertaining to metabolic balances, notably those of calcium, phosphorus, and nitrogen. , 1945, The Journal of clinical endocrinology and metabolism.

[33]  H. C. Harrison,et al.  THE RENAL EXCRETION OF INORGANIC PHOSPHATE IN RELATION TO THE ACTION OF VITAMIN D AND PARATHYROID HORMONE. , 1941, The Journal of clinical investigation.

[34]  S. H. Liu,et al.  CALCIUM AND PHOSPHORUS METABOLISM IN OSTEOMALACIA X. FURTHER STUDIES ON VITAMIN D ACTION: EARLY SIGNS OF DEPLETION AND EFFECT OF MINIMAL DOSES. , 1940, The Journal of clinical investigation.

[35]  F. Albright,et al.  Rickets resistant to vitamin D therapy. , 1937 .